SOUTHWEST ONCOLOGY GROUP

西南肿瘤集团

• 批准号: 7224242
• 负责人: THOMAS Patrick MILLER
• 金额: $ 26.64万
• 依托单位: UNIVERSITY OF ARIZONA
• 依托单位国家: 美国
• 财政年份: 1978
• 资助国家: 美国
• 起止时间: 1978-01-01 至 2009-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7224242
• 关键词: Affect; Arizona; Awareness; Cancer Center; Clinical Research; Clinical Trials; Disadvantaged; Discipline; Disease; Elderly; Funding Applicant; Human; Intervention; Laboratories; Leadership; Malignant Neoplasms; Minority; Patient Care; Patients; Physicians; Protocols documentation; Quality Control; Research; Services; Southwest Oncology Group; Testing; Universities; cancer therapy; follow-up; improved; named group; outreach; outreach program; quality assurance; repository

DESCRIPTION (provided by applicant): Funding is requested to support Arizona Cancer Center (University of Arizona) participation in Southwest Oncology Group (SWOG) cooperative cancer clinical research to improve the treatment of cancer in humans. Specific aims and objectives are: 1. To continue to meet our current scientific leadership and core service commitments including: (a) protocol coordination (multiple studies); (b) disease and discipline committee administration; (c) reference and repository laboratory administration; (d) group quality assurance and quality control. 2. To continue to promote the rapid integration of promising new research leads, including those developed at the Arizona Cancer Center, into cooperative group testing to improve patient treatment options and patient care. 3. To continue to meet our institutional clinical research commitments in the recruitment of appropriate patients for SWOG and SWOG-endorsed studies and all attendant commitments to Iong-term follow-up, quality assurance, quality control, etc. 4. To continue to promote physician and patient awareness of and participation in SWOG and SWOG-endorsed clinical trials and outreach programs. 5. To continue efforts to understand factors affecting accrual, particularly those in special populations (e.g., minority, elderly, financially disadvantaged), and to implement appropriate interventions where possible.

描述(由申请者提供)：申请资助以支持亚利桑那癌症中心(亚利桑那大学)参与西南肿瘤学集团(SWOG)合作的癌症临床研究，以改善人类癌症的治疗。具体的目标和目标是： 1.继续履行我们目前的科学领导和核心服务承诺，包括：(A)方案协调(多项研究)；(B)疾病和纪律委员会管理；(C)参考和资料库实验室管理；(D)团体质量保证和质量控制。 2.继续推动将有希望的新研究线索，包括亚利桑那州癌症中心开发的那些，迅速整合到合作的团体测试中，以改善患者的治疗选择和患者护理。 3.继续履行我们的机构临床研究承诺，为SWOG和SWOG认可的研究招募合适的患者，以及所有随之而来的长期随访、质量保证和质量控制等承诺。 4.继续促进医生和患者对SWOG和SWOG批准的临床试验和推广计划的认识和参与。 5.继续努力了解影响应计利润的因素，特别是特殊人群(如少数群体、老年人、经济困难群体)的因素，并在可能的情况下采取适当的干预措施。